Events

Latest Articles

ARTICLE

Happy 2025 – more churn for MDR and IVDR!

Erik Vollebregt

Happy new year everyone! I hope you had a good rest over the holidays because 2025 will be interesting. I am planning to revive this blog this year and hope to put new energy in it by making it more periodical with smaller bits of information and shorter analysis. You will still get my unique […]
Filter articles on Medical Devices Legal
Filter articles on Axon
ARTICLE

Impossible and Incredible And Yet Really Happened

Karin Verzijden What can we learn from the Impossible vs. Incredible case in the Netherlands? At the end May this year, the Court of The Hague rendered a remarkable judgment: at the request of Impossible Foods, Nestlé was banned from launching its INCREDIBLE BURGER in the EU. How is this possible? Impossible Foods is not even on […]
Filter articles on Food Health Legal

More Articles

Article

Autumn College on EU Food Law

, Karin Verzijden This year is the 4th edition of a 2-days seminar on two particular topics of EU Food Law, notably health claims and food information. Karin created this event, together with Lexxion, in…
Read more

Article

Axon seminar on General Data Protection Regulation

, Erik Vollebregt The EU General Data Protection Regulation (GDPR) text has been finalized and the regulation will enter into force soon, setting the legal framework for processing of personal data in the EU for…
Read more

Article

Axon Seminar on Alternative Sources of Protein

, Karin Verzijden Wednesday 25 November Axon organizes a seminar with the focus on the economical, societal and commercial impact of alternative sources of protein and on its legal implications. Program & Invitation

Download

Axon Seminar Cell-based Therapies Wednesday 18 April 2012

, Karin Verzijden The seminar addressed current and future EU legal and regulatory developments relevant to cell-based therapies. In particular, the seminar focused on how to choose and support the right regulatory pathway for a…
Read more

Article

Axon Seminar Cell-based Therapies Wednesday 18 April 2012

, Carine van den Brink The seminar addressed current and future EU legal and regulatory developments relevant to cell-based therapies. In particular, the seminar focused on how to choose and support the right regulatory pathway for a…
Read more

Navigate through our knowledgebase

advertisingappsauthorised representativeBorderlinebusiness complianceCE MarkCE markingClinical evaluationClinical investigationClinical TrialsCybersecurityData ProtectioneHealthenforcementENVIEucomedEudamedfoodhealthhealth claimsIn vitro diagnosticsinformationIVDIVDRivdslabellingLiesemarket surveillanceMDRMEDDEVMedical devicesmhealthNotified Bodiesnotified bodyNovel Foodnutrition claimspersonal dataPMAPMSprivacyQuality systemRecastreprocessingrevisionRoth-BehrendtSoftwarestandardstechnologyUDIUnannounced audits